![](https://webarchive.library.unt.edu/eot2008/20090118123651im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Prescription and Over-the-Counter Drug Product List
27th Edition
Cumulative Supplement Number 2: February 2007
NOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend. ![PDF](https://webarchive.library.unt.edu/eot2008/20090118123651im_/http://www.fda.gov/cder/graphics/pdf.gif)
ABARELIX
INJECTABLE; INTRAMUSCULAR
PLENAXIS
>D> @ PRAECIS 100MG/VIAL N21320 001 Nov 25, 2003 Feb CAHN
>A> @ SPECIALITY EUROPEAN 100MG/VIAL N21320 001 Nov 25, 2003 Feb CAHN
ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
TABLET; ORAL
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE
>D> AB + MIKART 712.8MG;60MG;32MG N40316 001 Apr 28, 1999 Feb CTEC
>A> AA + 712.8MG;60MG;32MG N40316 001 Apr 28, 1999 Feb CTEC
ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITATRATE
>D> AB WEST WARD 712.8MG;60MG;32MG N40637 001 Sep 22, 2006 Feb CTEC
>A> AA 712.8MG;60MG;32MG N40637 001 Sep 22, 2006 Feb CTEC
ACETAMINOPHEN; HYDROCODONE BITARTRATE
TABLET; ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>A> AA INTERPHARM 500MG;10MG N40813 001 Feb 23, 2007 Feb NEWA
ALPRAZOLAM
TABLET, EXTENDED RELEASE; ORAL
ALPRAZOLAM
>A> AB TEVA PHARMS 0.5MG N77979 001 Feb 28, 2007 Feb NEWA
>A> AB 1MG N77979 002 Feb 28, 2007 Feb NEWA
>A> AB 2MG N77979 003 Feb 28, 2007 Feb NEWA
>A> AB 3MG N77979 004 Feb 28, 2007 Feb NEWA
TABLET; ORAL
ALPRAZOLAM
>D> @ CLONMEL HLTHCARE 0.25MG N74174 001 Oct 19, 1993 Feb CAHN
>D> @ 0.5MG N74174 002 Oct 19, 1993 Feb CAHN
>D> @ 1MG N74174 003 Oct 19, 1993 Feb CAHN
>D> @ 2MG N74174 004 Oct 19, 1993 Feb CAHN
>A> @ DAVA INTL INC 0.25MG N74174 001 Oct 19, 1993 Feb CAHN
>A> @ 0.5MG N74174 002 Oct 19, 1993 Feb CAHN
>A> @ 1MG N74174 003 Oct 19, 1993 Feb CAHN
>A> @ 2MG N74174 004 Oct 19, 1993 Feb CAHN
ARIPIPRAZOLE
TABLET, ORALLY DISINTEGRATING; ORAL
ABILIFY
>D> OTSUKA 10MG N21729 002 Jun 07, 2006 Feb CRLD
>A> + 10MG N21729 002 Jun 07, 2006 Feb CRLD
>D> + 30MG N21729 005 Jun 07, 2006 Feb CRLD
>A> 30MG N21729 005 Jun 07, 2006 Feb CRLD
TABLET; ORAL
ABILIFY
>D> + OTSUKA 15MG N21436 002 Nov 15, 2002 Feb CRLD
>A> 15MG N21436 002 Nov 15, 2002 Feb CRLD
>D> + 30MG N21436 004 Nov 15, 2002 Feb CRLD
>A> 30MG N21436 004 Nov 15, 2002 Feb CRLD
BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT; OPHTHALMIC
>D> CORTISPORIN
>D> AT MONARCH PHARMS 400 UNITS/GM;1%;EQ 3.5MG N50416 002 Feb DISC
>A> @ 400 UNITS/GM;1%;EQ 3.5MG N50416 002 Feb DISC
NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE
>D> AT + BAUSCH AND LOMB 400 UNITS/GM;1%;EQ 3.5MG N64068 001 Oct 30, 1995 Feb CTEC
>A> + 400 UNITS/GM;1%;EQ 3.5MG N64068 001 Oct 30, 1995 Feb CTEC
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
OINTMENT; OPHTHALMIC
>D> NEOSPORIN
>D> AT MONARCH PHARMS 400 UNITS/GM;EQ 3.5MG N50417 001 Feb DISC
>A> @ 400 UNITS/GM;EQ 3.5MG N50417 001 Feb DISC
BACITRACIN ZINC; POLYMYXIN B SULFATE
OINTMENT; OPHTHALMIC
>D> POLYSPORIN
>D> AT MONARCH PHARMS 500 UNITS/GM;10,000 UNITS/GM N61229 001 Feb DISC
>A> @ 500 UNITS/GM;10,000 UNITS/GM N61229 001 Feb DISC
BUDESONIDE
POWDER, METERED; INHALATION
>D> BUDESONIDE
>D> ASTRAZENECA 0.08MG/INH N21949 001 Jul 12, 2006 Feb CTNA
>D> + 0.16MG/INH N21949 002 Jul 12, 2006 Feb CTNA
>A> PULMICORT FLEXHALER
>A> ASTRAZENECA 0.08MG/INH N21949 001 Jul 12, 2006 Feb CTNA
>A> + 0.16MG/INH N21949 002 Jul 12, 2006 Feb CTNA
CABERGOLINE
TABLET; ORAL
CABERGOLINE
>A> AB IVAX PHARMS INC 0.5MG N77750 001 Mar 07, 2007 Feb NEWA
CARISOPRODOL
TABLET; ORAL
CARISOPRODOL
>A> AA SUN PHARM INDS LTD 350MG N40755 001 Feb 27, 2007 Feb NEWA
CEFTIZOXIME SODIUM
INJECTABLE; INJECTION
CEFIZOX
>D> ASTELLAS EQ 1GM BASE/VIAL N63294 002 Mar 31, 1994 Feb CRLD
>A> + EQ 1GM BASE/VIAL N63294 002 Mar 31, 1994 Feb CRLD
>D> + EQ 1GM BASE/VIAL N50560 002 Sep 15, 1983 Feb DISC
>A> @ EQ 1GM BASE/VIAL N50560 002 Sep 15, 1983 Feb DISC
CEFTRIAXONE SODIUM
INJECTABLE; IM-IV
CEFTRIAXONE
>A> AP HANFORD GC EQ 1GM BASE/VIAL N65268 001 Feb 28, 2007 Feb NEWA
>A> AP EQ 2GM BASE/VIAL N65268 002 Feb 28, 2007 Feb NEWA
INJECTABLE; INJECTION
CEFTRIAXONE
>A> AP HANFORD GC EQ 10GM BASE/VIAL N65269 001 Feb 28, 2007 Feb NEWA
CHLORAMPHENICOL SODIUM SUCCINATE
INJECTABLE; INJECTION
CHLORAMPHENICOL SODIUM SUCCINATE
>D> AP ABRAXIS PHARM EQ 1GM BASE/VIAL N62365 001 Aug 25, 1982 Feb CRLD
>A> + EQ 1GM BASE/VIAL N62365 001 Aug 25, 1982 Feb CRLD
>D> CHLOROMYCETIN
>D> AP + PARKEDALE EQ 1GM BASE/VIAL N50155 001 Feb DISC
>A> @ EQ 1GM BASE/VIAL N50155 001 Feb DISC
CHLOROTHIAZIDE
SUSPENSION; ORAL
DIURIL
>D> + MERCK 250MG/5ML N11870 001 Feb CAHN
>A> + SALIX PHARMS 250MG/5ML N11870 001 Feb CAHN
CITALOPRAM HYDROBROMIDE
>A> CAPSULE; ORAL
>A> CITALOPRAM HYDROBROMIDE
>A> ALPHAPHARM EQ 10MG BASE N77668 001 Feb 28, 2007 Feb NEWA
>A> EQ 20MG BASE N77668 002 Feb 28, 2007 Feb NEWA
>A> + EQ 40MG BASE N77668 003 Feb 28, 2007 Feb NEWA
CLOBETASOL PROPIONATE
SOLUTION; TOPICAL
CLOBETASOL PROPIONATE
>D> @ ALTANA 0.05% N75391 001 Feb 08, 1999 Feb CMFD
>A> AT 0.05% N75391 001 Feb 08, 1999 Feb CMFD
CLONIDINE HYDROCHLORIDE
TABLET; ORAL
CLONIDINE HYDROCHLORIDE
>A> AB VINTAGE 0.1MG N77901 001 Mar 09, 2007 Feb NEWA
>A> AB 0.2MG N77901 002 Mar 09, 2007 Feb NEWA
>A> AB 0.3MG N77901 003 Mar 09, 2007 Feb NEWA
CYCLOBENZAPRINE HYDROCHLORIDE
>A> CAPSULE, EXTENDED RELEASE; ORAL
>A> AMRIX
>A> ECR 15MG N21777 001 Feb 01, 2007 Feb NEWA
>A> + 30MG N21777 002 Feb 01, 2007 Feb NEWA
TABLET; ORAL
CYCLOBENZAPRINE HYDROCHLORIDE
>A> AB VINTAGE PHARMS 5MG N77797 001 Feb 28, 2007 Feb NEWA
>A> AB 10MG N77797 002 Feb 28, 2007 Feb NEWA
DEXTROAMPHETAMINE SULFATE
TABLET; ORAL
>D> DEXEDRINE
>D> AA GLAXOSMITHKLINE 5MG N84935 001 Feb DISC
>A> @ 5MG N84935 001 Feb DISC
DIDANOSINE
FOR SOLUTION; ORAL
>A> DIDANOSINE
>A> AA AUROBINDO PHARMA 10MG/ML N78112 001 Mar 08, 2007 Feb NEWA
VIDEX
>D> + BRISTOL MYERS 10MG/ML N20156 001 Oct 09, 1991 Feb CFTG
>A> AA + 10MG/ML N20156 001 Oct 09, 1991 Feb CFTG
DIMYRISTOYL LECITHIN; PERFLEXANE
INJECTABLE; INTRAVENOUS
IMAGENT
>D> @ IMCOR PH 0.92MG/VIAL;0.092MG/VIAL N21191 001 May 31, 2002 Feb CAHN
>A> @ IMCOR PHARMS CO 0.92MG/VIAL;0.092MG/VIAL N21191 001 May 31, 2002 Feb CAHN
ESTRADIOL
TABLET; ORAL
ESTRADIOL
>A> @ HERITAGE PHARMS INC 0.5MG N40275 001 Dec 29, 1998 Feb CAHN
>A> @ 1MG N40275 002 Dec 29, 1998 Feb CAHN
>A> @ 2MG N40275 003 Dec 29, 1998 Feb CAHN
>D> @ RADIUS PHARMS 0.5MG N40275 001 Dec 29, 1998 Feb CAHN
>D> @ 1MG N40275 002 Dec 29, 1998 Feb CAHN
>D> @ 2MG N40275 003 Dec 29, 1998 Feb CAHN
FAMOTIDINE
FOR SUSPENSION; ORAL
PEPCID
>D> + MERCK 40MG/5ML N19527 001 Feb 02, 1987 Feb CAHN
>A> + SALIX PHARMS 40MG/5ML N19527 001 Feb 02, 1987 Feb CAHN
FENOLDOPAM MESYLATE
INJECTABLE; INJECTION
FENOLDOPAM MESYLATE
>A> AP SICOR PHARMS EQ 10MG BASE/ML N77826 001 Mar 07, 2007 Feb NEWA
FINASTERIDE
TABLET; ORAL
FINASTERIDE
>A> AB DR REDDYS LABS 5MG N76437 001 Feb 28, 2007 Feb NEWA
FLUPHENAZINE HYDROCHLORIDE
TABLET; ORAL
FLUPHENAZINE HYDROCHLORIDE
>D> AB MYLAN 10MG N89804 001 Aug 12, 1988 Feb CRLD
>A> AB + 10MG N89804 001 Aug 12, 1988 Feb CRLD
GABAPENTIN
TABLET; ORAL
GABAPENTIN
>D> AB IVAX PHARMS 800MG N76017 005 Apr 29, 2005 Feb CRLD
>A> AB + 800MG N76017 005 Apr 29, 2005 Feb CRLD
NEURONTIN
>D> AB + PFIZER PHARMS 800MG N20882 002 Oct 09, 1998 Feb CRLD
>A> AB 800MG N20882 002 Oct 09, 1998 Feb CRLD
HEPARIN SODIUM
INJECTABLE; INJECTION
HEPARIN SODIUM
>A> @ WATSON LABS 1,000 UNITS/ML N17064 002 Feb CAHN
>A> @ 2,500 UNITS/ML N17064 015 Feb CAHN
>A> @ 3,000 UNITS/ML N17064 016 Feb CAHN
>A> @ 4,000 UNITS/ML N17064 017 Feb CAHN
>A> @ 5,000 UNITS/ML N17064 003 Feb CAHN
>A> @ 6,000 UNITS/ML N17064 018 Feb CAHN
>A> @ 7,500 UNITS/ML N17064 019 Feb CAHN
>A> @ 10,000 UNITS/ML N17064 004 Feb CAHN
>A> @ 20,000 UNITS/ML N17064 005 Feb CAHN
>A> @ 40,000 UNITS/ML N17064 006 Feb CAHN
>D> @ WATSON PHARMS 1,000 UNITS/ML N17064 002 Feb CAHN
>D> @ 2,500 UNITS/ML N17064 015 Feb CAHN
>D> @ 3,000 UNITS/ML N17064 016 Feb CAHN
>D> @ 4,000 UNITS/ML N17064 017 Feb CAHN
>D> @ 5,000 UNITS/ML N17064 003 Feb CAHN
>D> @ 6,000 UNITS/ML N17064 018 Feb CAHN
>D> @ 7,500 UNITS/ML N17064 019 Feb CAHN
>D> @ 10,000 UNITS/ML N17064 004 Feb CAHN
>D> @ 20,000 UNITS/ML N17064 005 Feb CAHN
>D> @ 40,000 UNITS/ML N17064 006 Feb CAHN
HYDRALAZINE HYDROCHLORIDE
TABLET; ORAL
HYDRALAZINE HYDROCHLORIDE
>A> @ HERITAGE PHARMS INC 25MG N86243 001 Feb CAHN
>A> @ 50MG N86242 002 Feb CAHN
>D> @ RADIUS PHARMS 25MG N86243 001 Feb CAHN
>D> @ 50MG N86242 002 Feb CAHN
HYDROCHLOROTHIAZIDE
TABLET; ORAL
HYDROCHLOROTHIAZIDE
>A> AB ACTAVIS ELIZABETH 12.5MG N40707 001 Feb 27, 2007 Feb NEWA
>A> AB HERITAGE PHARMS INC 25MG N85181 001 Feb CAHN
>A> AB 50MG N85182 001 Feb CAHN
>D> AB LEINER 25MG N85181 001 Feb CAHN
>D> AB 50MG N85182 001 Feb CAHN
>D> MYLAN 12.5MG N40770 001 Jan 23, 2007 Feb CTEC
>A> AB 12.5MG N40770 001 Jan 23, 2007 Feb CTEC
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
TABLET; ORAL
>A> MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
>A> AB TEVA 12.5MG;7.5MG N76980 001 Mar 07, 2007 Feb NEWA
>A> AB 12.5MG;15MG N76980 003 Mar 07, 2007 Feb NEWA
>A> AB 25MG;15MG N76980 002 Mar 07, 2007 Feb NEWA
UNIRETIC
>D> SCHWARZ PHARMA 12.5MG;7.5MG N20729 001 Jun 27, 1997 Feb CFTG
>A> AB 12.5MG;7.5MG N20729 001 Jun 27, 1997 Feb CFTG
>D> 12.5MG;15MG N20729 003 Feb 14, 2002 Feb CFTG
>A> AB 12.5MG;15MG N20729 003 Feb 14, 2002 Feb CFTG
>D> + 25MG;15MG N20729 002 Jun 27, 1997 Feb CFTG
>A> AB + 25MG;15MG N20729 002 Jun 27, 1997 Feb CFTG
HYDROCORTISONE
TABLET; ORAL
CORTEF
>D> @ PHARMACIA AND 10MG N08697 001 Feb CMFD
>A> 10MG N08697 001 Feb CMFD
HYDROMORPHONE HYDROCHLORIDE
INJECTABLE; INJECTION
HYDROMORPHONE HYDROCHLORIDE
>D> AP WATSON LABS 10MG/ML N74317 001 Aug 23, 1995 Feb DISC
>A> @ 10MG/ML N74317 001 Aug 23, 1995 Feb DISC
HYDROXYZINE HYDROCHLORIDE
INJECTABLE; INJECTION
HYDROXYZINE HYDROCHLORIDE
>D> AP HOSPIRA 25MG/ML N87416 001 Feb DISC
>A> @ 25MG/ML N87416 001 Feb DISC
>D> AP 50MG/ML N87546 001 Feb DISC
>A> @ 50MG/ML N87546 001 Feb DISC
>D> AP WATSON LABS 50MG/ML N85779 001 Feb DISC
>A> @ 50MG/ML N85779 001 Feb DISC
ILOPROST
SOLUTION; INHALATION
VENTAVIS
>D> + ACTELION 10UGM/ML (10UGM/ML) N21779 002 Dec 08, 2005 Feb CAHN
>D> + 20UGM/2ML (10UGM/ML) N21779 001 Dec 29, 2004 Feb CAHN
>A> + ACTELION PHARM 10UGM/ML (10UGM/ML) N21779 002 Dec 08, 2005 Feb CAHN
>A> + 20UGM/2ML (10UGM/ML) N21779 001 Dec 29, 2004 Feb CAHN
INDOMETHACIN
CAPSULE; ORAL
INDOMETHACIN
>A> @ HERITAGE PHARMS INC 25MG N18851 001 May 18, 1984 Feb CAHN
>A> @ 50MG N18851 002 May 18, 1984 Feb CAHN
>D> MYLAN 25MG N18858 001 Apr 20, 1984 Feb CTEC
>A> AB 25MG N18858 001 Apr 20, 1984 Feb CTEC
>D> @ RADIUS PHARMS 25MG N18851 001 May 18, 1984 Feb CAHN
>D> @ 50MG N18851 002 May 18, 1984 Feb CAHN
>D> @ SANDOZ 25MG N70673 001 Apr 29, 1987 Feb CMFD
>A> AB 25MG N70673 001 Apr 29, 1987 Feb CMFD
>D> @ 50MG N70674 001 Apr 29, 1987 Feb CMFD
>A> AB 50MG N70674 001 Apr 29, 1987 Feb CMFD
IRON SUCROSE
INJECTABLE; INTRAVENOUS
VENOFER
>D> LUITPOLD EQ 50MG BASE/2.5ML(EQ 20MG BASE/ML) N21135 002 Mar 20, 2005 Feb DISC
>A> @ EQ 50MG BASE/2.5ML(EQ 20MG BASE/ML) N21135 002 Mar 20, 2005 Feb DISC
>D> EQ 75MG BASE/3.75ML(EQ 20MG N21135 003 Mar 29, 2005 Feb DISC
>A> @ EQ 75MG BASE/3.75ML(EQ 20MG N21135 003 Mar 29, 2005 Feb DISC
>A> EQ 200MG BASE/10ML(EQ 20MG N21135 004 Feb 09, 2007 Feb NEWA
KETOPROFEN
CAPSULE; ORAL
KETOPROFEN
>A> AB HERITAGE PHARMS INC 25MG N74014 001 Jan 29, 1993 Feb CAHN
>A> AB 50MG N74014 002 Jan 29, 1993 Feb CAHN
>A> AB 75MG N74014 003 Jan 29, 1993 Feb CAHN
>D> AB RADIUS PHARMS 25MG N74014 001 Jan 29, 1993 Feb CAHN
>D> AB 50MG N74014 002 Jan 29, 1993 Feb CAHN
>D> AB 75MG N74014 003 Jan 29, 1993 Feb CAHN
LIDOCAINE HYDROCHLORIDE
SOLUTION; ORAL
LIDOCAINE HYDROCHLORIDE VISCOUS
>A> AT VINTAGE 2% N40708 001 Feb 27, 2007 Feb NEWA
SOLUTION; TOPICAL
LIDOCAINE HYDROCLORIDE
>A> AT VINTAGE 4% N40710 001 Feb 27, 2007 Feb NEWA
>A> LISDEXAMFETAMINE DIMESYLATE
>A> CAPSULE; ORAL
>A> VYVANSE
>A> NEW RIVER 30MG N21977 001 Feb 23, 2007 Feb NEWA
>A> 50MG N21977 002 Feb 23, 2007 Feb NEWA
>A> + 70MG N21977 003 Feb 23, 2007 Feb NEWA
LOVASTATIN
TABLET, EXTENDED RELEASE; ORAL
ALTOPREV
>D> ANDRX LABS LLC 10MG N21316 001 Jun 26, 2002 Feb DISC
>A> @ 10MG N21316 001 Jun 26, 2002 Feb DISC
TABLET; ORAL
LOVASTATIN
>A> AB APOTEX INC 10MG N77748 001 Feb 28, 2007 Feb NEWA
>A> AB 20MG N77748 002 Feb 28, 2007 Feb NEWA
>A> AB 40MG N77748 003 Feb 28, 2007 Feb NEWA
METHYLPHENIDATE HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
CONCERTA
>D> ALZA 18MG N21121 001 Aug 01, 2000 Feb CAHN
>D> 27MG N21121 004 Apr 01, 2002 Feb CAHN
>D> 36MG N21121 002 Aug 01, 2000 Feb CAHN
>D> + 54MG N21121 003 Dec 08, 2000 Feb CAHN
>A> JOHNSON AND 18MG N21121 001 Aug 01, 2000 Feb CAHN
>A> 27MG N21121 004 Apr 01, 2002 Feb CAHN
>A> 36MG N21121 002 Aug 01, 2000 Feb CAHN
>A> + 54MG N21121 003 Dec 08, 2000 Feb CAHN
METHYLPREDNISOLONE SODIUM SUCCINATE
INJECTABLE; INJECTION
METHYLPREDNISOLONE SODIUM SUCCINATE
>A> AP BEDFORD LABS EQ 40MG BASE/VIAL N40662 001 Feb 21, 2007 Feb NEWA
>A> AP EQ 125MG BASE/VIAL N40641 002 Feb 21, 2007 Feb NEWA
>A> AP EQ 500MG BASE/VIAL N40709 001 Feb 21, 2007 Feb NEWA
>A> AP EQ 500MG BASE/VIAL N40641 003 Feb 21, 2007 Feb NEWA
>A> AP EQ 1GM BASE/VIAL N40709 002 Feb 21, 2007 Feb NEWA
>A> AP EQ 1GM BASE/VIAL N40641 004 Feb 21, 2007 Feb NEWA
MIDAZOLAM HYDROCHLORIDE
INJECTABLE; INJECTION
>D> MIDAZOLAM HYDROCHLORIDE
>D> AP + HOSPIRA EQ 1MG BASE/ML N75857 001 Jul 22, 2002 Feb CTNA
>D> AP + EQ 5MG BASE/ML N75857 002 Jul 22, 2002 Feb CTNA
>A> AP TAYLOR EQ 1MG BASE/ML N75494 001 Jun 30, 2000 Feb CAHN
>A> AP EQ 5MG BASE/ML N75494 002 Jun 30, 2000 Feb CAHN
>D> AP TAYLOR PHARMA EQ 1MG BASE/ML N75494 001 Jun 30, 2000 Feb CAHN
>D> AP EQ 5MG BASE/ML N75494 002 Jun 30, 2000 Feb CAHN
>A> MIDAZOLAM HYDROCHLORIDE PRESERVATIVE FREE
>A> AP + HOSPIRA EQ 1MG BASE/ML N75857 001 Jul 22, 2002 Feb CTNA
>A> AP + EQ 5MG BASE/ML N75857 002 Jul 22, 2002 Feb CTNA
MORPHINE SULFATE
CAPSULE, EXTENDED RELEASE; ORAL
KADIAN
>A> ALPHARMA US 200MG N20616 007 Feb 27, 2007 Feb NEWA
NALBUPHINE HYDROCHLORIDE
INJECTABLE; INJECTION
NALBUPHINE HYDROCHLORIDE
>D> AP HOSPIRA 10MG/ML N70915 001 Feb 03, 1989 Feb CRLD
>A> AP + 10MG/ML N70915 001 Feb 03, 1989 Feb CRLD
>D> AP 10MG/ML N70914 001 Feb 03, 1989 Feb CRLD
>A> AP + 10MG/ML N70914 001 Feb 03, 1989 Feb CRLD
>D> AP 20MG/ML N70918 001 Feb 03, 1989 Feb CRLD
>A> AP + 20MG/ML N70918 001 Feb 03, 1989 Feb CRLD
>D> AP 20MG/ML N70916 001 Feb 03, 1989 Feb CRLD
>A> AP + 20MG/ML N70916 001 Feb 03, 1989 Feb CRLD
>D> NUBAIN
>D> AP + ENDO PHARMS 10MG/ML N18024 001 Feb DISC
>A> @ 10MG/ML N18024 001 Feb DISC
>D> AP + 20MG/ML N18024 002 May 27, 1982 Feb DISC
>A> @ 20MG/ML N18024 002 May 27, 1982 Feb DISC
NESIRITIDE RECOMBINANT
FOR SOLUTION; INTRAVENOUS
NATRECOR
>D> + ALZA CORP 1.5MG/VIAL N20920 001 Aug 10, 2001 Feb CAHN
>A> + SCIOS 1.5MG/VIAL N20920 001 Aug 10, 2001 Feb CAHN
ONDANSETRON HYDROCHLORIDE
INJECTABLE; INJECTION
ONDANSETRON HYDROCHLORIDE AND DEXTROSE IN PLASTIC CONTAINER
>A> AP MAYNE PHARMA USA EQ 0.64MG BASE/ML N76978 001 Feb 26, 2007 Feb NEWA
OXYCODONE HYDROCHLORIDE
TABLET; ORAL
ROXICODONE
>D> AB + XANODYNE PHARM 15MG N21011 001 Aug 31, 2000 Feb CAHN
>D> AB 30MG N21011 002 Aug 31, 2000 Feb CAHN
>A> AB + XANODYNE PHARMS 15MG N21011 001 Aug 31, 2000 Feb CAHN
>A> AB 30MG N21011 002 Aug 31, 2000 Feb CAHN
PAROXETINE HYDROCHLORIDE
TABLET; ORAL
PAROXETINE HYDROCHLORIDE
>A> AB ZYDUS PHARMS USA EQ 10MG BASE N77584 001 Mar 07, 2007 Feb NEWA
>A> AB EQ 20MG BASE N77584 002 Mar 07, 2007 Feb NEWA
>A> AB EQ 30MG BASE N77584 003 Mar 07, 2007 Feb NEWA
>A> AB EQ 40MG BASE N77584 004 Mar 07, 2007 Feb NEWA
PENTOXIFYLLINE
TABLET, EXTENDED RELEASE; ORAL
PENTOXIFYLLINE
>A> AB HERITAGE PHARMS INC 400MG N74877 001 Jul 08, 1997 Feb CAHN
>D> AB RADIUS PHARMS 400MG N74877 001 Jul 08, 1997 Feb CAHN
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL
PHENTERMINE HYDROCHLORIDE
>D> AA AMBI PHARMS 30MG N40083 001 Mar 07, 1997 Feb CAHN
>D> AA SANDOZ 30MG N87190 001 Feb CRLD
>A> AA + 30MG N87190 001 Feb CRLD
>A> AA TG UNITED INC 30MG N40083 001 Mar 07, 1997 Feb CAHN
PILOCARPINE HYDROCHLORIDE
TABLET; ORAL
PILOCARPINE HYDROCHLORIDE
>A> AB ROXANE 7.5MG N76963 002 Feb 27, 2007 Feb NEWA
PIPERACILLIN SODIUM
INJECTABLE; INJECTION
PIPERACILLIN
>D> + ABRAXIS PHARM EQ 2GM BASE/VIAL N65114 001 Nov 14, 2003 Feb CAHN
>D> + EQ 3GM BASE/VIAL N65114 002 Nov 14, 2003 Feb CAHN
>D> + EQ 4GM BASE/VIAL N65114 003 Nov 14, 2003 Feb CAHN
>D> + EQ 40GM BASE/VIAL N65157 001 Jul 12, 2004 Feb CAHN
>A> + ISTITUTO BIOCHIMICO EQ 2GM BASE/VIAL N65114 001 Nov 14, 2003 Feb CAHN
>A> + EQ 3GM BASE/VIAL N65114 002 Nov 14, 2003 Feb CAHN
>A> + EQ 4GM BASE/VIAL N65114 003 Nov 14, 2003 Feb CAHN
>A> + EQ 40GM BASE/VIAL N65157 001 Jul 12, 2004 Feb CAHN
PREDNICARBATE
OINTMENT; TOPICAL
DERMATOP
>D> + SANOFI AVENTIS US 0.1% N19568 001 Sep 23, 1991 Feb CFTG
>A> AB + 0.1% N19568 001 Sep 23, 1991 Feb CFTG
>A> PREDNICARBATE
>A> AB ALTANA 0.1% N77236 001 Mar 09, 2007 Feb NEWA
PROCHLORPERAZINE
SUPPOSITORY; RECTAL
>D> COMPAZINE
>D> AB + GLAXOSMITHKLINE 25MG N11127 002 Feb DISC
>A> @ 25MG N11127 002 Feb DISC
PROCHLORPERAZINE
>D> AB G AND W LABS 25MG N40058 001 Nov 24, 1993 Feb CRLD
>A> AB + 25MG N40058 001 Nov 24, 1993 Feb CRLD
PROCHLORPERAZINE EDISYLATE
INJECTABLE; INJECTION
>D> COMPAZINE
>D> AP + GLAXOSMITHKLINE EQ 5MG BASE/ML N10742 002 Feb DISC
>A> @ EQ 5MG BASE/ML N10742 002 Feb DISC
>D> PROCHLORPERAZINE
>D> AP BAXTER HLTHCARE EQ 5MG BASE/ML N87759 001 Oct 01, 1982 Feb DISC
>A> @ EQ 5MG BASE/ML N87759 001 Oct 01, 1982 Feb DISC
PROCHLORPERAZINE EDISYLATE
>D> AP BAXTER HLTHCARE EQ 5MG BASE/ML N89903 001 Aug 29, 1989 Feb CRLD
>A> AP + EQ 5MG BASE/ML N89903 001 Aug 29, 1989 Feb CRLD
>D> AP HOSPIRA EQ 5MG BASE/ML N89703 001 Apr 07, 1988 Feb DISC
>A> @ EQ 5MG BASE/ML N89703 001 Apr 07, 1988 Feb DISC
>D> AP WATSON LABS EQ 5MG BASE/ML N89530 001 Jul 08, 1987 Feb DISC
>A> @ EQ 5MG BASE/ML N89530 001 Jul 08, 1987 Feb DISC
PROCHLORPERAZINE MALEATE
TABLET; ORAL
>D> COMPAZINE
>D> AB GLAXOSMITHKLINE EQ 5MG BASE N10571 001 Feb DISC
>A> @ EQ 5MG BASE N10571 001 Feb DISC
>D> AB EQ 10MG BASE N10571 002 Feb DISC
>A> @ EQ 10MG BASE N10571 002 Feb DISC
>D> AB + EQ 25MG BASE N10571 003 Feb DISC
>A> @ EQ 25MG BASE N10571 003 Feb DISC
PROCHLORPERAZINE MALEATE
>D> AB SANDOZ EQ 10MG BASE N40101 002 Jul 19, 1996 Feb CRLD
>A> AB + EQ 10MG BASE N40101 002 Jul 19, 1996 Feb CRLD
>D> AB EQ 25MG BASE N40101 003 Jul 19, 1996 Feb DISC
>A> @ EQ 25MG BASE N40101 003 Jul 19, 1996 Feb DISC
PROPOXYPHENE HYDROCHLORIDE
CAPSULE; ORAL
DOLENE
>A> @ HERITAGE PHARMS INC 65MG N80530 001 Feb CAHN
>D> @ RADIUS PHARMS 65MG N80530 001 Feb CAHN
PROPRANOLOL HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
PROPRANOLOL HYDROCHLORIDE
>A> AB MYLAN 60MG N78022 001 Feb 15, 2007 Feb NEWA
>A> AB 80MG N78022 002 Feb 15, 2007 Feb NEWA
>A> AB 120MG N78022 003 Feb 15, 2007 Feb NEWA
>A> AB 160MG N78022 004 Feb 15, 2007 Feb NEWA
RABEPRAZOLE SODIUM
TABLET, DELAYED RELEASE; ORAL
ACIPHEX
>D> + EISAI MEDCL RES 20MG N20973 002 Aug 19, 1999 Feb CFTG
>A> AB + 20MG N20973 002 Aug 19, 1999 Feb CFTG
>A> RABEPRAZOLE SODIUM
>A> AB TEVA 20MG N76822 001 Feb 21, 2007 Feb NEWA
RAMIPRIL
>A> TABLET; ORAL
>A> ALTACE
>A> COBALT 1.25MG N22021 001 Feb 27, 2007 Feb NEWA
>A> 2.5MG N22021 002 Feb 27, 2007 Feb NEWA
>A> 5MG N22021 003 Feb 27, 2007 Feb NEWA
>A> + 10MG N22021 004 Feb 27, 2007 Feb NEWA
RANITIDINE HYDROCHLORIDE
SYRUP; ORAL
>A> RANITIDINE HYDROCHLORIDE
>A> AA ALPHARMA US EQ 15MG BASE/ML N76124 001 Feb 21, 2007 Feb NEWA
ZANTAC
>D> + GLAXOSMITHKLINE EQ 15MG BASE/ML N19675 001 Dec 30, 1988 Feb CFTG
>A> AA + EQ 15MG BASE/ML N19675 001 Dec 30, 1988 Feb CFTG
SERMORELIN ACETATE
INJECTABLE; INJECTION
GEREF
>A> + EMD SERONO EQ 0.05MG BASE/AMP N19863 001 Dec 28, 1990 Feb CAHN
>A> @ EQ 0.5MG BASE/VIAL N20443 001 Sep 26, 1997 Feb CAHN
>A> @ EQ 1MG BASE/VIAL N20443 002 Sep 26, 1997 Feb CAHN
>D> + SERONO EQ 0.05MG BASE/AMP N19863 001 Dec 28, 1990 Feb CAHN
>D> @ EQ 0.5MG BASE/VIAL N20443 001 Sep 26, 1997 Feb CAHN
>D> @ EQ 1MG BASE/VIAL N20443 002 Sep 26, 1997 Feb CAHN
SERTRALINE HYDROCHLORIDE
CONCENTRATE; ORAL
SERTRALINE HYDROCHLORIDE
>D> AB RANBAXY EQ 20MG BASE/ML N78053 001 Feb 05, 2007 Feb CTEC
>A> AA EQ 20MG BASE/ML N78053 001 Feb 05, 2007 Feb CTEC
>D> AB ROXANE EQ 20MG BASE/ML N76934 001 Jun 30, 2006 Feb CTEC
>A> AA EQ 20MG BASE/ML N76934 001 Jun 30, 2006 Feb CTEC
ZOLOFT
>D> AB + PFIZER EQ 20MG BASE/ML N20990 001 Dec 07, 1999 Feb CTEC
>A> AA + EQ 20MG BASE/ML N20990 001 Dec 07, 1999 Feb CTEC
SODIUM LACTATE
INJECTABLE; INJECTION
SODIUM LACTATE IN PLASTIC CONTAINER
>D> HOSPIRA 5MEQ/ML N18947 001 Sep 05, 1984 Feb CRLD
>A> + 5MEQ/ML N18947 001 Sep 05, 1984 Feb CRLD
SOMATROPIN RECOMBINANT
INJECTABLE; INJECTION
SAIZEN
>A> BX EMD SERONO 4MG/VIAL N19764 005 Jan 16, 2007 Feb CAHN
>A> BX 5MG/VIAL N19764 002 Oct 08, 1996 Feb CAHN
>A> @ 6MG/VIAL N19764 001 Oct 08, 1996 Feb CAHN
>A> + 8.8MG/VIAL N19764 003 Aug 29, 2000 Feb CAHN
>D> BX SERONO 4MG/VIAL N19764 005 Jan 16, 2007 Feb CAHN
>D> BX 5MG/VIAL N19764 002 Oct 08, 1996 Feb CAHN
>D> @ 6MG/VIAL N19764 001 Oct 08, 1996 Feb CAHN
>D> + 8.8MG/VIAL N19764 003 Aug 29, 2000 Feb CAHN
SEROSTIM
>A> BX EMD SERONO 4MG/VIAL N20604 003 Jul 25, 1997 Feb CAHN
>A> BX 5MG/VIAL N20604 002 Aug 23, 1996 Feb CAHN
>A> BX 6MG/VIAL N20604 001 Aug 23, 1996 Feb CAHN
>A> @ 8.8MG/VIAL N20604 004 Sep 06, 2001 Feb CAHN
>D> BX SERONO 4MG/VIAL N20604 003 Jul 25, 1997 Feb CAHN
>D> BX 5MG/VIAL N20604 002 Aug 23, 1996 Feb CAHN
>D> BX 6MG/VIAL N20604 001 Aug 23, 1996 Feb CAHN
>D> @ 8.8MG/VIAL N20604 004 Sep 06, 2001 Feb CAHN
INJECTABLE; SUBCUTANEOUS
SEROSTIM LQ
>A> @ EMD SERONO 6MG/0.5ML N20604 005 Feb 11, 2005 Feb CAHN
>D> @ SERONO 6MG/0.5ML N20604 005 Feb 11, 2005 Feb CAHN
SULFAMETHOXAZOLE; TRIMETHOPRIM
INJECTABLE; INJECTION
>D> BACTRIM
>D> AP + MUTUAL PHARM 80MG/ML;16MG/ML N18374 001 Feb DISC
>A> @ 80MG/ML;16MG/ML N18374 001 Feb DISC
SUSPENSION; ORAL
>D> BACTRIM PEDIATRIC
>D> AB MUTUAL PHARM 200MG/5ML;40MG/5ML N17560 002 Feb DISC
>A> @ 200MG/5ML;40MG/5ML N17560 002 Feb DISC
>D> SEPTRA
>D> AB + MONARCH PHARMS 200MG/5ML;40MG/5ML N17598 001 Feb DISC
>A> @ 200MG/5ML;40MG/5ML N17598 001 Feb DISC
>D> SEPTRA GRAPE
>D> AB MONARCH PHARMS 200MG/5ML;40MG/5ML N17598 002 Feb 12, 1986 Feb DISC
>A> @ 200MG/5ML;40MG/5ML N17598 002 Feb 12, 1986 Feb DISC
SULFAMETHOXAZOLE AND TRIMETHOPRIM
>D> AB TEVA 200MG/5ML;40MG/5ML N18812 001 Jan 28, 1983 Feb DISC
>A> @ 200MG/5ML;40MG/5ML N18812 001 Jan 28, 1983 Feb DISC
>D> AB 200MG/5ML;40MG/5ML N18812 002 Jun 10, 1983 Feb DISC
>A> @ 200MG/5ML;40MG/5ML N18812 002 Jun 10, 1983 Feb DISC
>D> AB TEVA PHARMS 200MG/5ML;40MG/5ML N77612 001 Nov 13, 2006 Feb CRLD
>A> AB + 200MG/5ML;40MG/5ML N77612 001 Nov 13, 2006 Feb CRLD
SULFASALAZINE
TABLET; ORAL
SULFASALAZINE
>A> @ HERITAGE PHARMS INC 500MG N80197 001 Feb CAHN
>D> @ RADIUS PHARMS 500MG N80197 001 Feb CAHN
SULINDAC
TABLET; ORAL
SULINDAC
>A> @ HERITAGE PHARMS INC 150MG N73262 002 Sep 06, 1991 Feb CAHN
>A> @ 200MG N73262 001 Sep 06, 1991 Feb CAHN
>D> @ RADIUS PHARMS 150MG N73262 002 Sep 06, 1991 Feb CAHN
>D> @ 200MG N73262 001 Sep 06, 1991 Feb CAHN
TERCONAZOLE
SUPPOSITORY; VAGINAL
TERCONAZOLE
>A> AB TARO 80MG N77553 001 Mar 09, 2007 Feb NEWA
THEOPHYLLINE
TABLET, EXTENDED RELEASE; ORAL
>D> QUIBRON-T/SR
>D> BC MONARCH PHARMS 300MG N87563 001 Jun 21, 1983 Feb DISC
>A> @ 300MG N87563 001 Jun 21, 1983 Feb DISC
TABLET; ORAL
>D> QUIBRON-T
>D> + MONARCH PHARMS 300MG N88656 001 Aug 22, 1985 Feb DISC
>A> @ 300MG N88656 001 Aug 22, 1985 Feb DISC
TRAMADOL HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
>D> TRAMADOL HYDROCHLORIDE
>D> BIOVAIL LABS INTL 100MG N21692 001 Sep 08, 2005 Feb CTNA
>D> 200MG N21692 002 Sep 08, 2005 Feb CTNA
>D> + 300MG N21692 003 Sep 08, 2005 Feb CTNA
>A> ULTRAM ER
>A> BIOVAIL LABS INTL 100MG N21692 001 Sep 08, 2005 Feb CTNA
>A> 200MG N21692 002 Sep 08, 2005 Feb CTNA
>A> + 300MG N21692 003 Sep 08, 2005 Feb CTNA
VERAPAMIL HYDROCHLORIDE
INJECTABLE; INJECTION
>D> ISOPTIN
>D> AP + FSC 2.5MG/ML N18485 001 Feb DISC
>A> @ 2.5MG/ML N18485 001 Feb DISC
VERAPAMIL HYDROCHLORIDE
>D> AP LUITPOLD 2.5MG/ML N70617 001 Nov 12, 1985 Feb CRLD
>A> AP + 2.5MG/ML N70617 001 Nov 12, 1985 Feb CRLD
>D> AP 2.5MG/ML N70225 001 Nov 12, 1985 Feb DISC
>A> @ 2.5MG/ML N70225 001 Nov 12, 1985 Feb DISC
TABLET; ORAL
CALAN
>D> AB GD SEARLE LLC 120MG N18817 002 Sep 10, 1984 Feb CRLD
>A> AB + 120MG N18817 002 Sep 10, 1984 Feb CRLD
>D> ISOPTIN
>D> AB FSC 40MG N18593 003 Nov 23, 1987 Feb DISC
>A> @ 40MG N18593 003 Nov 23, 1987 Feb DISC
>D> AB 80MG N18593 001 Mar 08, 1982 Feb DISC
>A> @ 80MG N18593 001 Mar 08, 1982 Feb DISC
>D> AB + 120MG N18593 002 Mar 08, 1982 Feb DISC
>A> @ 120MG N18593 002 Mar 08, 1982 Feb DISC
VERAPAMIL HYDROCHLORIDE
>A> @ HERITAGE PHARMS INC 80MG N71880 001 Apr 05, 1988 Feb CAHN
>A> @ 120MG N71881 001 Apr 05, 1988 Feb CAHN
>D> @ RADIUS PHARMS 80MG N71880 001 Apr 05, 1988 Feb CAHN
>D> @ 120MG N71881 001 Apr 05, 1988 Feb CAHN
ZONISAMIDE
CAPSULE; ORAL
ZONISAMIDE
>A> AB COREPHARMA 25MG N77876 001 Feb 21, 2007 Feb NEWA
>A> AB 50MG N77876 002 Feb 21, 2007 Feb NEWA
>A> AB 100MG N77876 003 Feb 21, 2007 Feb NEWA
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL
SPONGE; TOPICAL
CHLORAPREP WITH TINT
>A> + ENTURIA INC 2%;70% (3ML) N20832 007 Oct 10, 2006 Feb NEWA
DOXYLAMINE SUCCINATE
TABLET; ORAL
UNISOM
>A> + CHATTEM 25MG N18066 001 Feb CAHN
>D> + MCNEIL CONS 25MG N18066 001 Feb CAHN
NONOXYNOL-9
SPONGE; VAGINAL
TODAY
>D> @ ALLENDALE PHARMS 1GM N18683 001 Apr 01, 1983 Feb CMFD
>A> + 1GM N18683 001 Apr 01, 1983 Feb CMFD
ORLISTAT
CAPSULE; ORAL
>A> ALLI
>A> + GLAXOSMITHKLINE 60MG N21887 001 Feb 07, 2007 Feb NEWA
RANITIDINE HYDROCHLORIDE
TABLET, EFFERVESCENT; ORAL
ZANTAC 75
>A> @ BOEHRINGER EQ 75MG BASE N20745 001 Feb 26, 1998 Feb CAHN
>D> @ MCNEIL CONS EQ 75MG BASE N20745 001 Feb 26, 1998 Feb CAHN
Back
to Top
Back to Additions/Deletions Index
Date created: March 15, 2007; updated August 8, 2007 |
![](https://webarchive.library.unt.edu/eot2008/20090118123651im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |